Hypothalamic growth hormone receptor (GHR) controls hepatic glucose production in nutrient-sensing leptin receptor (LepRb) expressing neurons

[1]  M. Metzger,et al.  Distribution of growth hormone-responsive cells in the mouse brain , 2016, Brain Structure and Function.

[2]  A. Bartke,et al.  Growth hormone modulates hypothalamic inflammation in long‐lived pituitary dwarf mice , 2015, Aging cell.

[3]  F. Steyn,et al.  Nutrient Sensing Overrides Somatostatin and Growth Hormone‐Releasing Hormone to Control Pulsatile Growth Hormone Release , 2015, Journal of neuroendocrinology.

[4]  M. Birnbaum,et al.  Hepatic Insulin Signaling is Dispensable for Suppression of Glucose Output by Insulin in Vivo , 2015, Nature Communications.

[5]  B. Lowell,et al.  TRAP-seq defines markers for novel populations of hypothalamic and brainstem LepRb neurons , 2015, Molecular metabolism.

[6]  M. Schwartz,et al.  Control of hepatic glucose metabolism by islet and brain , 2014, Diabetes, obesity & metabolism.

[7]  Elizabeth A. Jensen,et al.  Liver-specific GH receptor gene-disrupted (LiGHRKO) mice have decreased endocrine IGF-I, increased local IGF-I, and altered body size, body composition, and adipokine profiles. , 2014, Endocrinology.

[8]  Ana I. Domingos,et al.  Profiling of Glucose-Sensing Neurons Reveals that GHRH Neurons Are Activated by Hypoglycemia. , 2013, Cell metabolism.

[9]  W. Freeman,et al.  Insulin-like growth factor-1 in CNS and cerebrovascular aging , 2013, Front. Aging Neurosci..

[10]  G. Johannsson,et al.  The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations , 2013, Nature Reviews Endocrinology.

[11]  G. Anderson,et al.  Neither signal transducer and activator of transcription 3 (STAT3) or STAT5 signaling pathways are required for leptin's effects on fertility in mice. , 2013, Endocrinology.

[12]  V. Longo,et al.  Somatotropic signaling: trade-offs between growth, reproductive development, and longevity. , 2013, Physiological reviews.

[13]  Noor Akhter,et al.  Ablation of leptin signaling to somatotropes: changes in metabolic factors that cause obesity. , 2012, Endocrinology.

[14]  Tasneem S. Ansari,et al.  Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice , 2011, Journal of visualized experiments : JoVE.

[15]  C. Kahn,et al.  Elevated GH/IGF-I, due to somatotrope-specific loss of both IGF-I and insulin receptors, alters glucose homeostasis and insulin sensitivity in a diet-dependent manner. , 2011, Endocrinology.

[16]  D. Burdakov,et al.  Neuropeptide Y cells represent a distinct glucose-sensing population in the lateral hypothalamus. , 2011, Endocrinology.

[17]  Robert C. Thompson,et al.  Leptin action via neurotensin neurons controls orexin, the mesolimbic dopamine system and energy balance. , 2011, Cell metabolism.

[18]  D. Leroith,et al.  The Intricate Role of Growth Hormone in Metabolism , 2011, Front. Endocrin..

[19]  J. Kopchick,et al.  Endocrine parameters and phenotypes of the growth hormone receptor gene disrupted (GHR-/-) mouse. , 2011, Endocrine reviews.

[20]  R. Zechner,et al.  Brain insulin controls adipose tissue lipolysis and lipogenesis. , 2011, Cell metabolism.

[21]  Andrzej Bartke,et al.  Growth hormone, insulin and aging: The benefits of endocrine defects , 2011, Experimental Gerontology.

[22]  A. Bookout,et al.  Characterization of Kiss1 neurons using transgenic mouse models , 2011, Neuroscience.

[23]  L. Seoane,et al.  The vagus nerve as a regulator of growth hormone secretion , 2011, Regulatory Peptides.

[24]  S. Bouret,et al.  Large litter rearing enhances leptin sensitivity and protects selectively bred diet-induced obese rats from becoming obese. , 2010, Endocrinology.

[25]  Clifford B Saper,et al.  Identifying the efferent projections of leptin‐responsive neurons in the dorsomedial hypothalamus using a novel conditional tracing approach , 2010, The Journal of comparative neurology.

[26]  K. Rahmouni Leptin-Induced Sympathetic Nerve Activation: Signaling Mechanisms and Cardiovascular Consequences in Obesity. , 2010, Current hypertension reviews.

[27]  D. Leroith,et al.  Biological effects of growth hormone on carbohydrate and lipid metabolism. , 2010, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[28]  Gary D Bader,et al.  The Genetic Landscape of a Cell , 2010, Science.

[29]  M. White,et al.  Deletion of Irs 2 Causes Reduced Kidney Size in Mice : Role for Inhibition of GSK 3 β ? , 2010 .

[30]  M. White,et al.  Deletion of Irs2 causes reduced kidney size in mice: role for inhibition of GSK3β? , 2010, BMC Developmental Biology.

[31]  M. White,et al.  Human IL6 enhances leptin action in mice , 2009, Diabetologia.

[32]  A. Means,et al.  Faculty Opinions recommendation of The ectopic expression of Pax4 in the mouse pancreas converts progenitor cells into alpha and subsequently beta cells. , 2009 .

[33]  O. Madsen,et al.  The Ectopic Expression of Pax4 in the Mouse Pancreas Converts Progenitor Cells into α and Subsequently β Cells , 2009, Cell.

[34]  G. Leinninger Location, location, location: the CNS sites of leptin action dictate its regulation of homeostatic and hedonic pathways , 2009, International Journal of Obesity.

[35]  J. Kopchick,et al.  Growth hormone improves body composition, fasting blood glucose, glucose tolerance and liver triacylglycerol in a mouse model of diet-induced obesity and type 2 diabetes , 2009, Diabetologia.

[36]  Niels Møller,et al.  Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. , 2009, Endocrine reviews.

[37]  M. Kearney,et al.  Role of IGF-1 in glucose regulation and cardiovascular disease , 2008, Expert review of cardiovascular therapy.

[38]  C. Kahn,et al.  Central insulin action regulates peripheral glucose and fat metabolism in mice. , 2008, The Journal of clinical investigation.

[39]  R. Printz,et al.  Central Nervous System Neuropeptide Y Signaling Modulates VLDL Triglyceride Secretion , 2008, Diabetes.

[40]  F. Ashcroft,et al.  Insulin action in AgRP-expressing neurons is required for suppression of hepatic glucose production. , 2007, Cell metabolism.

[41]  C. Magnan,et al.  Free fatty acids and insulin resistance , 2007, Current opinion in clinical nutrition and metabolic care.

[42]  H. Münzberg,et al.  Leptin Receptor Signaling and Action in the Central Nervous System , 2006, Obesity.

[43]  E. Kang,et al.  Effects of growth hormone on insulin resistance and atherosclerotic risk factors in obese type 2 diabetic patients with poor glycaemic control , 2006, Clinical endocrinology.

[44]  G. Norstedt,et al.  Negative regulation of growth hormone receptor signaling. , 2006, Molecular endocrinology.

[45]  C. Saper,et al.  Expression of ghrelin receptor mRNA in the rat and the mouse brain , 2006, The Journal of comparative neurology.

[46]  F. Nyberg,et al.  Distribution of growth hormone receptor mRNA in the brain stem and spinal cord of the rat , 2005, Neuroscience.

[47]  A. Pocai,et al.  Central leptin acutely reverses diet-induced hepatic insulin resistance. , 2005, Diabetes.

[48]  I. Robinson,et al.  Hypothalamic STAT Proteins: Regulation of Somatostatin Neurones by Growth Hormone Via STAT5b , 2005, Journal of neuroendocrinology.

[49]  A. Pocai,et al.  A brain-liver circuit regulates glucose homeostasis. , 2005, Cell metabolism.

[50]  C. Bruder,et al.  Growth hormone overexpression in the central nervous system results in hyperphagia-induced obesity associated with insulin resistance and dyslipidemia. , 2005, Diabetes.

[51]  M. White,et al.  Insulin receptor substrate proteins and diabetes , 2004, Archives of pharmacal research.

[52]  R. Osamura,et al.  Leptin and the Pituitary , 2004, Pituitary.

[53]  L. Rossetti,et al.  Hypothalamic insulin signaling is required for inhibition of glucose production , 2002, Nature Medicine.

[54]  H. Watanobe,et al.  Leptin Regulates Growth Hormone-Releasing Factor, Somatostatin, and α-Melanocyte-Stimulating Hormone But Not Neuropeptide Y Release in Rat Hypothalamus In Vivo: Relation with Growth Hormone Secretion , 2002, The Journal of Neuroscience.

[55]  C. Ohlsson,et al.  Liver-Derived IGF-I Regulates GH Secretion at the Pituitary Level in Mice. , 2001, Endocrinology.

[56]  J. Herrington,et al.  Signaling pathways activated by the growth hormone receptor , 2001, Trends in Endocrinology & Metabolism.

[57]  Y. Song,et al.  Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients , 2001, International Journal of Obesity.

[58]  Richard A. Miller,et al.  Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[59]  D. Alessi Discovery of PDK1, one of the missing links in insulin signal transduction. Colworth Medal Lecture , 2001 .

[60]  D. Alessi Discovery of PDK1, one of the missing links in insulin signal transduction. Colworth Medal Lecture. , 2001, Biochemical Society transactions.

[61]  차봉수 Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients , 2001 .

[62]  K. Nonogaki,et al.  New insights into sympathetic regulation of glucose and fat metabolism , 2000, Diabetologia.

[63]  M. Matsuhisa,et al.  Important role of the hepatic vagus nerve in glucose uptake and production by the liver. , 2000, Metabolism: clinical and experimental.

[64]  J. Hyde,et al.  The human growth hormone-releasing hormone transgenic mouse as a model of modest obesity: differential changes in leptin receptor (OBR) gene expression in the anterior pituitary and hypothalamus after fasting and OBR localization in somatotrophs. , 1999, Endocrinology.

[65]  M. Nishihara,et al.  Obesity and insulin resistance in human growth hormone transgenic rats. , 1998, Endocrinology.

[66]  P. Kelly,et al.  Growth-hormone-receptor and cytokine-receptor-family signaling. , 1998, European journal of biochemistry.

[67]  J. Kamegai,et al.  Growth hormone receptor gene is expressed in neuropeptide Y neurons in hypothalamic arcuate nucleus of rats. , 1996, Endocrinology.

[68]  R. Steiner,et al.  Regulation of hypothalamic neuropeptide-Y neurons by growth hormone in the rat. , 1996, Endocrinology.

[69]  J. Ihle STATs: Signal Transducers and Activators of Transcription , 1996, Cell.

[70]  J. de Belleroche,et al.  Cyclooxygenase‐2 Induction in Cerebral Cortex: An Intracellular Response to Synaptic Excitation , 1996, Journal of neurochemistry.

[71]  G. Shulman,et al.  Local Ventromedial Hypothalamus Glucopenia Triggers Counterregulatory Hormone Release , 1995, Diabetes.

[72]  N. Barzilai,et al.  Role of glucokinase and glucose-6-phosphatase in the acute and chronic regulation of hepatic glucose fluxes by insulin. , 1993, The Journal of biological chemistry.

[73]  M. Waters,et al.  Localization and ontogeny of growth hormone receptor gene expression in the central nervous system. , 1993, Brain research. Developmental brain research.

[74]  D. Clemmons,et al.  Treatment of obese, diet-restricted subjects with growth hormone for 11 weeks: effects on anabolism, lipolysis, and body composition. , 1988, The Journal of clinical endocrinology and metabolism.

[75]  T. Claus,et al.  Hormonal regulation of hepatic gluconeogenesis and glycolysis. , 1988, Annual review of biochemistry.

[76]  P. Cryer,et al.  Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms. , 1987, The Journal of clinical investigation.

[77]  S. Hojvat,et al.  Growth hormone (GH) immunoreactivity in the rodent and primate CNS: Distribution, characterization and presence posthypophysectomy , 1982, Brain Research.

[78]  T. Shimazu Glycogen Synthetase Activity in Liver: Regulation by the Autonomic Nerves , 1967, Science.